Prognostic significance of Bcl-xL in human hepatocellular carcinoma
- 30 June 2004
- journal article
- Published by Elsevier BV in Surgery
- Vol. 135 (6), 604-612
- https://doi.org/10.1016/j.surg.2003.11.015
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 24 references indexed in Scilit:
- The Impact of Interferon Gamma Receptor Expression on the Mechanism of Escape From Host Immune Surveillance in Hepatocellular CarcinomaHepatology, 2000
- Overexpression of Bcl-2 protects human hepatoma cells from Fasantibody-mediated apoptosisJournal of Hepatology, 1999
- The alteration of fas receptor and ligand system in hepatocellular carcinomas: How do hepatoma cells escape from the host immune surveillancein vivo?Hepatology, 1999
- Altered expression of bcl-2 family member proteins in nonmelanoma skin cancerCancer, 1999
- An Optimized Immunohistochemical Protocol for Both Manual and Automated Staining of Formalin Fixed, Paraffin Embedded Human Placenta for Demonstration and Analyses of FAS, FAS-L, and Bcl-2Journal of Histotechnology, 1998
- Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinomaHepatology, 1997
- Inherent increase of apoptosis in liver tumors: Implications for carcinogenesis and tumor regressionHepatology, 1997
- Apoptosis and proliferation of human hepatocellular carcinomaLiver International, 1996
- New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections.Journal of Clinical Pathology, 1993
- Apoptosis and diseaseThe Lancet, 1993